Emerging Nano medicine

Currently,the treatment of HIV requires regular oral dosage of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies.Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown.Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle(SDN)technology which can improve drug absorption into the body,reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.

 

  • raphene Medicine
  • Image-guided drug delivery
  • Nanomedicine for Diabetes
  • Nanomedicine for Cancer
  • NanoMedicine for HIV

Related Conference of Emerging Nano medicine

December 10-11, 2020

21st World Summit on Nanotechnology and Expo

Osaka, Japan
February 10-11, 2021

32nd European Congress on Nanotechnology and Materials Engineering

Amsterdam, Netherlands
February 26-26, 2021

24th World Nanotechnology Congress

Abu Dhabi, UAE
April 28-29, 2021

33rd Nano Congress for Future Advancements

London, UK
May 21-22, 2021

18th Nanotechnology and Nano Medicine

Osaka, Japan
June 09-10, 2021

6th Annual Conference and Expo on Biomaterials

Berlin, Germany
August 03-04, 2021

4th World Congress on Nanoscience and Nano Technology

Hanoi, Vietnam
August 10-11, 2021

5th Annual Congress on Nanomedicine and Drug Delivery

Bangkok, Thailand
November 15-16, 2021

34th International Conference on Nanotechnology & Expo

Madrid, Spain

Emerging Nano medicine Conference Speakers

Recommended Sessions

Related Journals

Are you interested in